BioSpace News Archive

-- First targeted antibody of its kind to be evaluated as a conditioning agent in patients with hematologic cancer undergoing stem cell transplantation, an area of significant unmet need -- -- Investigational humanized monoclonal antibody also being evaluated in a separate Phase 1 study as a conditioning agent in patients with severe combined immunodeficiency -- REDWOOD CITY, Calif.--( BUSINESS WIRE )-- Jasper Therapeutics, Inc., a biotechnol

TPG Capital, the private equity platform of alternative asset firm TPG, announced today that it has formed a new specialty pharmaceutical company called Ellodi Pharmaceuticals. Ellodi Pharmaceuticals is dedicated to the clinical development of APT-1011, a novel therapy in Phase 3 development for the treatment of Eosinophilic Esophagitis (EoE) spun-out of Adare Pharmaceuticals (Adare).

Remedy Health Media (Remedy), a leading digital health platform and portfolio company of Topspin Consumer Partners, today announced the acquisition of OBR (Oncology Business Review), an oncology-focused digital media company that provides news and information resources to oncologists and oncology healthcare professionals (HCPs)

Genesys Orthopedic Systems (the “Company”), a leading developer of medical implants and instruments for spinal fusion procedures, announced today that it has completed a senior credit facility with a regional commercial lender. By providing capital with the goal of growing its market share, the multimillion-dollar facility wil

The Foundation hopes to meet the unique needs of stomach cancer patients and families during the pandemic.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the United States Patent and Trademark Office (USPTO) has issued the Company a new Notice of Allowance for a patent (Application No. 15/748,784) on anti-neoplastic compounds and methods targeting Quiescin Sulfhydryl Oxidase 1 (QSOX1), an enzyme impor

The National Kidney Foundation is partnering with the Centers for Disease Control and Prevention on spreading the word that everyone, especially patients with kidney disease, should get a flu vaccine this fall.

Naviswiss US announced the first successful U.S. surgery with its hand-held hip navigation system in New York City, NY. Dr. Alejandro Della Valle performed the procedure using the imageless system and accurately placing implants during a total hip replacement.

Medigate, the leader in IoT and medical device security and asset management, today announced that it has entered into an agreement with Arrow Electronics, Inc. to bring healthcare delivery organizations (HDOs) award-winning cybersecurity solutions for their connected devices.

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug candidate, in endometrial cancer.